torcetrapib

torcetrapib

美 　英

• 网络托彻普；托斯瑞比；托塞匹布

例句

Pfizer suddenly shut down the trial of torcetrapib and announced that the drug would not make it to market.

辉瑞突然中止了torcetrapib的试验，并宣布该药品将不可能面市销售。

But torcetrapib's failure could be the bitter medicine that Pfizer's entrenched bureaucracy needs to make it accept change.

但要治疗辉瑞根深蒂固的官僚作风，使其不得不接受变革，torcetrapib的失败可能是一剂苦口良药。

Torcetrapib's failure, Dr. Taylor said, shows that lowering cholesterol alone does not prove a drug will benefit patients.

对于Torcetrapib临床试验的失败，Taylor博士说，单纯地降低血液中胆固醇含量并不能代表一种药物对患者有益。

The drug, called torcetrapib, also reduced LDL, the bad cholesterol.

这种被命名为torcetrapib的药物还可降低有害胆固醇LDL的含量。

The latest study was small, involving just 19 patients, but its striking results suggest torcetrapib can have a powerful effect.

最近进行的研究规模较小，仅有19名患者参加，但是其结果具有显著意义，提示torcetrapib具有很强的效应。